Vir Biotechnology, Inc. (VIR) Stock Analysis — Probabli.AI
AI-powered analysis for VIR (Vir Biotechnology, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $9.10 · Market cap: $1.3B · AI consensus: Bullish
Vir Biotechnology exhibits strong potential for growth propelled by its innovative antiviral pipeline and collaborations. Recent successes in clinical trials and a STRONG BUY analyst consensus make it a compelling opportunity. However, regulatory and clinical execution remains crucial, as setbacks could pose risks. Probabilistic distribution indicates notable upside potential over 1-, 5-, and…
Probabilistic 1-Year Outlook
- Bull 6000% · Neutral 2500% · Bear 1500%
- The strong analyst consensus (STRONG BUY), high price targets, and recent positive developments, including successful trials and collaboration agreements, indicate potential strong near-term upside. However, some mixed…
5-Year Outlook
- Bull 5000% · Neutral 3500% · Bear 1500%
SWOT Highlights
- Strength: Promising antiviral pipeline
- Strength: Strong partnerships and collaborations
- Risk: Limited earnings surprise history
- Risk: Regulatory uncertainties
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
8 Wall Street analysts rate VIR a STRONG BUY with a mean price target of $19.63.
Analysis generated Mar 22, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/VIR.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.